Skip to contentT
Tenon Medical, Inc.
T
TNONWTenon Medical, Inc. Q3 2024 · 10-Q
Revenue$887.00K$887.00K−6.0% vs Q3 2023 Net Income-$3.18M-$3.18MN/M vs Q3 2023 EPS Diluted-$3.63-$3.63N/M vs Q3 2023 Gross Profit$418,000−21.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenon Medical, Inc. · CIK 1560293 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,343,000N/M Free Cash Flowderived-$2,447,000N/M Margins · derivedGross margin47.1%−9.5 pt vs Q3 2023
Operating margin-362.5%−4.6 pt vs Q3 2023
Net margin-359.0%−6.0 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end